Antibiotice Iași

Antibiotice Iași is a Romanian public pharmaceutical company headquartered in Iași, with research and manufacturing facilities in Valea Lupului, a commune near the city. The company is associated particularly with antibiotics, but its business extends across a broader portfolio of human medicines, veterinary products, and active pharmaceutical ingredients. It is described as one of Romania’s largest drug producers and is majority-owned by the Romanian Ministry of Health, which holds 53.02% of the company. The company’s human-health portfolio comprises approximately 150 medicines spanning 12 therapeutic areas. Its range includes generic medicines and specialty pharmaceutical products, with antibiotics forming a central part of its identity and commercial positioning. Antibiotice also manufactures veterinary medicines and produces active substances, including nystatin. This combination gives the company capabilities beyond finished-dose products and links its brand to both pharmaceutical manufacturing and selected upstream ingredients. Antibiotice’s production and research base is located near Iași rather than being distributed across a broad international network. From this Romanian base, the company serves the domestic market and exports products to multiple foreign markets. Reported destinations include the United Kingdom, the United States, Hungary, Lithuania, Iraq, Yemen, and Vietnam. The range of export markets indicates that the company operates as an international supplier while retaining a strong Romanian industrial and public-sector identity. The brand’s positioning is therefore built around accessible pharmaceutical manufacturing, established antibiotic expertise, and a diversified medicines portfolio. Its public ownership distinguishes it from privately controlled multinational pharmaceutical groups and makes the company relevant to Romania’s domestic medicines-production capacity. Available reference material does not provide sufficient detail to document a complete founding chronology, specific product brands, leadership history, financial performance, major acquisitions, or named marketing campaigns without risking unsupported claims.

Antibiotice Iași is a pharmaceutical manufacturing company based in Iași, Romania. Its research center and production facilities are located in Valea Lupului, near Iași. The company is publicly owned in the sense that a controlling 53.02% stake is held by Romania’s Ministry of Health, giving it a distinctive role within the country’s pharmaceutical industry. The available reference material characterizes Antibiotice as one of Romania’s largest drug-producing companies. Its activities cover the development and manufacture of medicines for human use, veterinary medicines, and active pharmaceutical substances. The human-medicines portfolio contains around 150 products distributed across 12 therapeutic areas. Antibiotics remain the core category associated with the company’s name and market identity, although the business is broader than antibiotic products alone. A notable feature of the company is its combination of finished pharmaceutical manufacturing and active-substance production. Nystatin is identified as one of its active pharmaceutical ingredients. This capability complements the company’s production of finished medicines and supports a positioning based on domestic industrial and technical capacity rather than only the marketing of externally manufactured brands. Antibiotice serves Romania while also exporting medicines internationally. Reported export destinations include the United Kingdom, United States, Hungary, Lithuania, Iraq, Yemen, and Vietnam. These markets span both European and non-European regions, indicating that the company’s output has an international commercial reach despite its concentrated Romanian production base. The supplied reference material does not establish a reliable founding year, identify a founder, provide a detailed sequence of corporate reorganizations, or document specific leadership appointments. It also does not provide verified information on individual product launch dates, revenue, stock-market status, acquisitions, campaigns, scandals, or major strategic decisions. Those areas are left unpopulated rather than inferred.

Romanian public pharmaceutical manufacturer focused on generic and specialty medicines, with particular strength in antibiotics, veterinary products, and selected active pharmaceutical ingredients.

• Human medicinesGeneric and specialty pharmaceuticals

  Antibiotice produces a broad portfolio of medicines for human use. The portfolio is reported to contain approximately 150 products across 12 therapeutic areas. Antibiotics are a central part of the company’s identity, while the wider range includes generic and specialty pharmaceutical products. Specific product-brand names and launch dates are not identified in the available reference material.

• AntibioticsHuman pharmaceuticals

  Antibiotic medicines are the category most closely associated with Antibiotice Iași. They form a core part of the company’s pharmaceutical manufacturing and positioning as a Romanian medicines producer. The available sources do not specify individual antibiotic brands, formulations, or product-generation histories.

• Veterinary medicinesVeterinary pharmaceuticals

  In addition to medicines for human use, Antibiotice manufactures veterinary medicines. This category broadens the company’s pharmaceutical scope beyond human healthcare and forms part of its diversified production portfolio. Specific veterinary products and markets are not detailed in the available sources.

• NystatinActive pharmaceutical ingredient

  Nystatin is identified as an active substance produced by Antibiotice. Its inclusion demonstrates that the company’s operations include selected active pharmaceutical ingredients as well as finished medicines. The available material does not specify production volumes, formulation partners, or the date of the product’s introduction.

1. Antibiotice Iași
2. Antibiotice official English website